BACKGROUND: To develop a positive aging phenotype, we undertook analyses to describe multiple dimensions of positive aging and their relationships to one another in women 65 years of age and older and evaluate the performance of individual indicators and composite factors of this phenotype as predictors of time to death, years of healthy living, and years of independent living. METHODS: Data from Women's Health Initiative clinical trial and observational study participants ages 65 years and older at baseline, including follow-up observations up to 8 years later, were analyzed using descriptive statistics and principal components analysis to identify the factor structure of a positive aging phenotype. The factors were used to predict time to death, years of healthy living (without hospitalization or diagnosis of a serious health condition), and years of independent living (without nursing home admission or use of special services). RESULTS: We identified a multidimensional phenotype of positive aging that included two factors: Physical-Social Functioning and Emotional Functioning. Both factors were predictive of each of the outcomes, but Physical-Social Functioning was the strongest predictor. Each standard deviation of increase in Physical-Social Functioning was accompanied by a 23.7% reduction in mortality risk, a 19.4% reduction in risk of major health conditions or hospitalizations, and a 26.3% reduction in risk of dependent living. CONCLUSIONS:Physical-Social Functioning and Emotional Functioning constitute important components of a positive aging phenotype. Physical-Social Functioning was the strongest predictor of outcomes related to positive aging, including years of healthy living, years of independent living, and time to mortality.
RCT Entities:
BACKGROUND: To develop a positive aging phenotype, we undertook analyses to describe multiple dimensions of positive aging and their relationships to one another in women 65 years of age and older and evaluate the performance of individual indicators and composite factors of this phenotype as predictors of time to death, years of healthy living, and years of independent living. METHODS: Data from Women's Health Initiative clinical trial and observational study participants ages 65 years and older at baseline, including follow-up observations up to 8 years later, were analyzed using descriptive statistics and principal components analysis to identify the factor structure of a positive aging phenotype. The factors were used to predict time to death, years of healthy living (without hospitalization or diagnosis of a serious health condition), and years of independent living (without nursing home admission or use of special services). RESULTS: We identified a multidimensional phenotype of positive aging that included two factors: Physical-Social Functioning and Emotional Functioning. Both factors were predictive of each of the outcomes, but Physical-Social Functioning was the strongest predictor. Each standard deviation of increase in Physical-Social Functioning was accompanied by a 23.7% reduction in mortality risk, a 19.4% reduction in risk of major health conditions or hospitalizations, and a 26.3% reduction in risk of dependent living. CONCLUSIONS: Physical-Social Functioning and Emotional Functioning constitute important components of a positive aging phenotype. Physical-Social Functioning was the strongest predictor of outcomes related to positive aging, including years of healthy living, years of independent living, and time to mortality.
Authors: J M Guralnik; L Ferrucci; C F Pieper; S G Leveille; K S Markides; G V Ostir; S Studenski; L F Berkman; R B Wallace Journal: J Gerontol A Biol Sci Med Sci Date: 2000-04 Impact factor: 6.053
Authors: K Yaffe; A J Fiocco; K Lindquist; E Vittinghoff; E M Simonsick; A B Newman; S Satterfield; C Rosano; S M Rubin; H N Ayonayon; T B Harris Journal: Neurology Date: 2009-06-09 Impact factor: 9.910
Authors: Graziano Onder; Brenda W J H Penninx; Pablo Lapuerta; Linda P Fried; Glenn V Ostir; Jack M Guralnik; Marco Pahor Journal: J Gerontol A Biol Sci Med Sci Date: 2002-05 Impact factor: 6.053
Authors: Patricia C Gregory; Sarah L Szanton; Qian-Li Xue; Jing Tian; Roland J Thorpe; Linda P Fried Journal: J Gerontol A Biol Sci Med Sci Date: 2011-03-07 Impact factor: 6.053
Authors: Mark S Kaplan; Nathalie Huguet; Heather Orpana; David Feeny; Bentson H McFarland; Nancy Ross Journal: J Gerontol A Biol Sci Med Sci Date: 2008-10 Impact factor: 6.053
Authors: Fredric D Wolinsky; Padmaja Ayyagari; Theodore K Malmstrom; J Phillip Miller; Elena M Andresen; Mario Schootman; Douglas K Miller Journal: J Gerontol A Biol Sci Med Sci Date: 2013-12-13 Impact factor: 6.053
Authors: Oleg Zaslavsky; Nancy F Woods; Andrea Z LaCroix; Jane A Cauley; Karen C Johnson; Barbara B Cochrane; Shira Zelber Sagi Journal: J Am Geriatr Soc Date: 2016-04 Impact factor: 5.562
Authors: Kelly R Ylitalo; Carrie Karvonen-Gutierrez; Candace McClure; Samar R El Khoudary; Elizabeth A Jackson; Barbara Sternfeld; Siobán D Harlow Journal: Diabetes Metab Res Rev Date: 2015-12-10 Impact factor: 4.876
Authors: Jennifer W Bea; Cynthia A Thomson; Betsy C Wertheim; J Skye Nicholas; Kacey C Ernst; Chengcheng Hu; Rebecca D Jackson; Jane A Cauley; Cora E Lewis; Bette Caan; Denise J Roe; Zhao Chen Journal: Am J Epidemiol Date: 2015-09-07 Impact factor: 4.897
Authors: Joseph S Goveas; Stephen R Rapp; Patricia E Hogan; Ira Driscoll; Hilary A Tindle; J Carson Smith; Shelli R Kesler; Oleg Zaslavsky; Rebecca C Rossom; Judith K Ockene; Kristine Yaffe; JoAnn E Manson; Susan M Resnick; Mark A Espeland Journal: J Gerontol A Biol Sci Med Sci Date: 2016-03 Impact factor: 6.053
Authors: Nancy Fugate Woods; Eileen Rillamas-Sun; Barbara B Cochrane; Andrea Z La Croix; Teresa E Seeman; Hilary A Tindle; Oleg Zaslavsky; Chloe E Bird; Karen C Johnson; JoAnn E Manson; Judith K Ockene; Rebecca A Seguin; Robert B Wallace Journal: J Gerontol A Biol Sci Med Sci Date: 2016-03 Impact factor: 6.053
Authors: Crystal W Cené; Peggye Dilworth-Anderson; Iris Leng; Lorena Garcia; Viola Benavente; Milagros Rosal; Leslie Vaughan; Laura H Coker; Giselle Corbie-Smith; Mimi Kim; Christina L Bell; Jennifer G Robinson; JoAnn E Manson; Barbara Cochrane Journal: J Gerontol A Biol Sci Med Sci Date: 2016-03 Impact factor: 6.053
Authors: Sandra Barral; Jatinder Singh; Erin Fagan; Stephanie Cosentino; Stacy L Andersen-Toomey; Mary K Wojczynski; Mary Feitosa; Candace M Kammerer; Nicole Schupf Journal: J Gerontol A Biol Sci Med Sci Date: 2017-11-09 Impact factor: 6.053